Hexarelin Reference

Educational, not medical advice reference for Hexarelin: GH Release; regulatory status, evidence posture, source review, and schedule notes. Als…

Plain English

What it is
Hexarelin is a lab-made peptide that tells the body to release a pulse of growth hormone. It is not approved by the FDA as a medicine. It is an older research peptide that has been studied in people, but it is not a finished, approved drug.
What people use it for
In community talk, people reach for it as a stronger, older option when gentler growth-hormone peptides feel too mild and they want a bigger growth-hormone effect. It is discussed for that reason, not because it is a tested treatment.
What the science shows
Older human studies show it triggers a strong growth-hormone release and can raise growth-related signals in the body. The same kind of research also shows it nudges up other hormones, including the stress hormone cortisol and the hormone prolactin. The studies are older and short, and there is no long-term safety research.
The catch
It is not an approved drug and has no modern long-term safety program. The body can get used to it over time, so the effect can fade, and the extra cortisol and prolactin are common concerns people raise. For research and educational purposes only. Not medical advice.

Reference summary

Human studies show strong GH release and some prolactin or cortisol effects relative to other secretagogues. Desensitization and off-target endocrine effects remain practical concerns in the literature.

Regulatory and posture

Categories
GH Release
Aliases
Growth hormone-releasing peptide 6 analog, GHRP class
Evidence posture
human - Older endocrine studies, not long-term outcome trials.
Regulatory status
No FDA-approved Hexarelin drug label. Human endocrine studies exist, but there is no approved therapeutic product or modern long-term safety program.
Content review status
research reference

Selected public sources

Related tools

For research and educational purposes only. Not medical advice.